跳至主要内容
临床试验/NCT04174586
NCT04174586招募中1 期

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年1月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
complete remission rate

研究概览

简要总结

Discuss the effectiveness and safety of cord blood microtransplantation for treatment of acute myeloid leukemia

详细描述

The investigators conducted a prospective, single center clinical trial to dissuss the outcomes and toxicities of HLA-mismatched cord blood infusion after chemotherapy (microtransplantation) in older patients with acute myeloid leukemia (AML)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • de novo acute myeloid leukemia

排除标准

  • have no suitable donor or donor refused
  • patient refused to accept donor cells

结局指标

主要结局

complete remission rate

时间窗: 1 month

Bone marrow \<5% blasts; Absolute neutrophil count \>1000/mcL; Platelets ≥100,000/mcL;No residual evidence of extramedullary disease.

time of hematopoietic recovery

时间窗: 1 month

Absolute neutrophil count \>500/mcL; Platelets ≥20,000/mcL

次要结局

  • time to progression(2 year)

研究者

发起方
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验